Gais, Sarah .
HRN: 26-46-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2025
CEFUROXIME 750MG (VIAL)
01/02/2025
01/09/2025
IV
530 Mg
Q8h
Anemia, Severe, ETBD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes